Inventurus Knowledge Solutions Ltd.
IKS · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹785.62.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%31.4%
- ✓Low debt (D/E < 0.5)0.27x
- ✓Positive free cash flow
- ✓Revenue growth > 10%19%
- ✓Earnings growing39%
- ✓Net margin ≥ 10%22.6%
- ✕Current ratio > 1.51.35
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 12.79
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Strong return on equity (31.4%).
- •Lightly leveraged balance sheet.
- •Healthy profit margin (22.6%).
- •Financially solid — Altman Z 12.79.
Opportunities
- •Earnings growing (39% YoY).
- •Revenue growing (19% YoY).
Threats
- •Rich valuation versus sector peers.
- •Trades ~41% above our estimated fair value.
About Inventurus Knowledge Solutions Ltd.
Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician businesses in outpatient and inpatient care activities in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical g
More in Information Technology
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.